ask="N/A"
ask_size="N/A"
average_daily_volume="20614"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.05"
change_from_200_day_moving_average="1.93"
change_from_50_day_moving_average="0.06"
change_from_52_week_high="-1.20"
change_From_52_week_low="4.30"
change_in_percent="-0.74%"
close="6.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.42"
eps_estimate_next_quarter="-0.16"
eps_estimate_next_year="-0.50"
ex_dividend_date="N/A"
float_shares="3301000"
high="6.90"
high_52_weeks="7.95"
last_trade_date="1/10/2017"
last_trade_price="6.75"
last_trade_size="100"
last_trade_time="4:00pm"
low="6.60"
low_52_weeks="2.45"
market_capitalization="193.79M"
moving_average_200_day="4.82"
moving_average_50_day="6.69"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="9.67"
open="6.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+39.93%"
percent_change_from_50_day_moving_average="+0.89%"
percent_change_from_52_week_high="-15.09%"
percent_change_from_52_week_low="+175.51%"
previous_close="6.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="15.38"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="1.67"
stock_exchange="ASE"
symbol="OCX"
volume="7903"
weeks_range_52="2.45 - 7.95"
